$1.66
-0.0314[-1.86%]
At close: Apr 19
$1.66
0[0.00%]
After Hours: 7:00AM EDT
Plus Therapeutics
(NASDAQ:PSTV)Plus Therapeutics Stock (NASDAQ:PSTV), Analyst Ratings, Price Targets, Predictions
Plus Therapeutics Inc has a consensus price target of $8.33, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on August 15, 2023, August 14, 2023, and June 30, 2023. With an average price target of $8 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 381.93% upside for Plus Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Maxim Group
JonesTrading
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Plus Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 08/15/2023 | PSTV | Buy Now | Plus Therapeutics | $1.66 | 381.93% | HC Wainwright & Co. | Sean Lee | → $8 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2023 | PSTV | Buy Now | Plus Therapeutics | $1.66 | 381.93% | HC Wainwright & Co. | Sean Lee | → $8 | Reiterates | Buy → Buy | Get Alert |
| 06/30/2023 | PSTV | Buy Now | Plus Therapeutics | $1.66 | 381.93% | HC Wainwright & Co. | Sean Lee | $3.5 → $8 | Maintains | Buy | Get Alert |
| 05/03/2023 | PSTV | Buy Now | Plus Therapeutics | $1.66 | 622.89% | Maxim Group | Jason McCarthy | $30 → $12 | Maintains | Buy | Get Alert |
| 04/21/2023 | PSTV | Buy Now | Plus Therapeutics | $1.66 | 110.84% | HC Wainwright & Co. | Sean Lee | → $52.5 | Reiterates | → Buy | Get Alert |
| 02/27/2023 | PSTV | Buy Now | Plus Therapeutics | $1.66 | 110.84% | HC Wainwright & Co. | Sean Lee | → $52.5 | Reiterates | → Buy | Get Alert |
| 10/07/2022 | PSTV | Buy Now | Plus Therapeutics | $1.66 | 201.2% | JonesTrading | Justin Walsh | → $75 | Initiates | → Buy | Get Alert |
| 07/22/2022 | PSTV | Buy Now | Plus Therapeutics | $1.66 | 110.84% | HC Wainwright & Co. | Sean Lee | $105 → $52.5 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Plus Therapeutics (PSTV)?
The latest price target for Plus Therapeutics (NASDAQ: PSTV) was reported by HC Wainwright & Co. on August 15, 2023. The analyst firm set a price target for $8.00 expecting PSTV to rise to within 12 months (a possible 381.93% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Plus Therapeutics (PSTV)?
The latest analyst rating for Plus Therapeutics (NASDAQ: PSTV) was provided by HC Wainwright & Co., and Plus Therapeutics reiterated their buy rating.
When was the last upgrade for Plus Therapeutics (PSTV)?
There is no last upgrade for Plus Therapeutics.
When was the last downgrade for Plus Therapeutics (PSTV)?
There is no last downgrade for Plus Therapeutics.
When is the next analyst rating going to be posted or updated for Plus Therapeutics (PSTV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Plus Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Plus Therapeutics was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
Is the Analyst Rating Plus Therapeutics (PSTV) correct?
While ratings are subjective and will change, the latest Plus Therapeutics (PSTV) rating was a reiterated with a price target of $0.00 to $8.00. The current price Plus Therapeutics (PSTV) is trading at is $1.66, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.